CGC (Canopy Growth Corp.) חוב לטווח ארוך

The biomedical sector of Canopy Growth (CGC) operates amid diplomatic stability, making the stock's chart on the GURU.Markets platform a convenient monitoring tool. The business relies on expanding its range of extracts and beverages for global markets to mitigate legal threats. However, financial stability remains weak due to oversupply and capital burn, while the long-term liabilities indicator stands at 0.17.

To objectively assess the issuer's credit profile, a manager requires an analysis of long-term liabilities via market value. This indicator filters out short-term volatility, reflecting the real dynamics of borrowings through the lens of daily trading. By analyzing the company's long-term debt, an investor determines the balance between financial stability and expansion rates. For Canopy Growth (CGC), this trend is critical due to high cash burn and unstable operating profit amid cannabis overproduction.